Cvijetić Selma, Keser Irena, Boschiero Dario, Ilich Jasminka Z
Division of Occupational and Environmental Health, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia.
Laboratory for Nutrition Science, Faculty of Food Technology and Biotechnology, University of Zagreb, Pierottijeva 6, 10000 Zagreb, Croatia.
J Pers Med. 2024 Jul 23;14(8):782. doi: 10.3390/jpm14080782.
Osteosarcopenic adiposity (OSA) syndrome, the coexistence of osteoporosis, sarcopenia, and adiposity (either excess or redistributed/infiltrated), has been studied globally in different populations and regions (mostly in East Asia, less in Europe and North America), resulting in varied prevalence. We aimed to determine the prevalence of OSA in a large population of apparently healthy Caucasian adults (18-90 years) and to compare it with the prevalence reported in other studies and other ethnicities. This study included 9719 participants (6412 women and 3307 men), stratified into four age-group categories, and recruited from the general medical practices in Italy. OSA was defined based on body composition measurements using bioelectrical impedance BIA-ACC, which enables assessment of total bone mass, muscle/lean, and adipose tissues. The overall prevalence of OSA was 21.9% in women and 14.0% in men, and it significantly increased in every subsequent age group for both women and men ( < 0.001). The OSA prevalence was not significantly different between men and women below 40 years; however, it was considerably higher in women over 40 years. Participants with OSA had a significantly lower BMI compared to those without OSA, indicating OSA is a separate disorder not necessarily related to physiological fluctuations of BMI. The prevalence in Asian populations was lower than in our sample, indicating ethnic specificity. The relatively high prevalence of OSA detected in this study's population across the age groups suggests the necessity for its appropriate and timely identification to prevent possible clinical outcomes, including fracture, dismobility, frailty, or chronic diseases.
骨肌少性肥胖(OSA)综合征,即骨质疏松症、肌肉减少症和肥胖(超重或脂肪重新分布/浸润)并存,已在全球不同人群和地区进行了研究(主要在东亚,在欧洲和北美较少),导致患病率各不相同。我们旨在确定一大群表面健康的白种成年人(18 - 90岁)中OSA的患病率,并将其与其他研究及其他种族报告的患病率进行比较。本研究纳入了9719名参与者(6412名女性和3307名男性),分为四个年龄组类别,从意大利的普通医疗诊所招募。OSA是根据使用生物电阻抗BIA - ACC进行的身体成分测量来定义的,该方法能够评估总骨量、肌肉/瘦体重和脂肪组织。OSA的总体患病率在女性中为21.9%,在男性中为14.0%,并且在随后的每个年龄组中,女性和男性的患病率均显著增加(<0.001)。40岁以下的男性和女性OSA患病率无显著差异;然而,40岁以上女性的患病率要高得多。与无OSA的参与者相比,患有OSA的参与者BMI显著更低,这表明OSA是一种独立的疾病,不一定与BMI的生理波动相关。亚洲人群的患病率低于我们的样本,表明存在种族特异性。本研究人群中各年龄组检测到的相对较高的OSA患病率表明,有必要对其进行适当及时的识别,以预防可能的临床后果,包括骨折、行动不便、虚弱或慢性疾病。